The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

Autor: Rätsep Indrek, Ravi Ramalingam R, Pachl Jan, Murillo-Cabezas Francisco, Mantilla Jorge, Hartzenberg Bennie, Frost Chris, Fletcher Olivia, Druwé Patrick, Dewan Yashbir, Quintero Juan, Boeriu Cristian, Balica Laura, Asser Toomas, Andrews Peter, Shakur Haleema, Sampaio Cristina, Singh Manmohan, Svoboda Petr, Roberts Ian

Publikováno v: Trials, Vol 10, Iss 1, p 109 (2009)

Abstract Background Cerebral oedema is associated with significant neurological damage in patients with traumatic brain injury. Bradykinin is an inflammatory mediator that may contribute to cerebral oedema by increasing the permeability of the blood-

Externí odkaz: https://doaj.org/article/c3d3cc45c140435c900e57d054bb0965

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Intractable Intracranial Tuberculous Infection Responsive to Thalidomide: Report of Four Cases.

Autor: Schoeman, Johan F., Fieggen, Graham, Seller, Neil, Mendelson, Marc, Hartzenberg, Bennie

Publikováno v: Journal of Child Neurology; Apr2006, Vol. 21 Issue 4, p301-308, 8p

Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial.

Autor: CRASH Trial Collaborators (CORPORATE AUTHOR), Roberts, Ian (AUTHOR), Yates, David (AUTHOR), Sandercock, Peter (AUTHOR), Farrell, Barbara (AUTHOR), Wasserberg, Jonathan (AUTHOR), Lomas, Gabrielle (AUTHOR), Cottingham, Rowland (AUTHOR), Svoboda, Petr (AUTHOR), Brayley, Nigel (AUTHOR), Mazairac, Guy (AUTHOR), Laloë, Véronique (AUTHOR), Muñoz-Sánchez, Angeles (AUTHOR), Arango, Miguel (AUTHOR), Hartzenberg, Bennie (AUTHOR), Khamis, Hussein (AUTHOR), Yutthakasemsunt, Surakrant (AUTHOR), Komolafe, Edward (AUTHOR), Olldashi, Fatos (AUTHOR), Yadav, Yadram (AUTHOR)

Publikováno v: Lancet. 10/9/2004, Vol. 364 Issue 9442, p1321-1328. 8p.

Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months.

Autor: Edwards P, Arango M, Balica L, Cottingham R, El-Sayed H, Farrell B, Fernandes J, Gogichaisvili T, Golden N, Hartzenberg B, Husain M, Ulloa MI, Jerbi Z, Khamis H, Komolafe E, Laloë V, Lomas G, Ludwig S, Mazairac G, Muñoz Sanchéz Mde L, Nasi L, Olldashi F, Plunkett P, Roberts I, Sandercock P, Shakur H, Soler C, Stocker R, Svoboda P, Trenkler S, Venkataramana NK, Wasserberg J, Yates D, Yutthakasemsunt S

Publikováno v: Lancet (London, England) [Lancet] 2005 Jun 4-10; Vol. 365 (9475), pp. 1957-9.